ArriVent BioPharma, Inc.
AVBP
$23.90
$1.024.44%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 27.40% | 33.85% | -19.55% | -22.62% | -5.29% |
| Total Receivables | 0.00% | 0.00% | 1.00% | 0.00% | -33.33% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -29.86% | -35.76% | 200.98% | -64.33% | -6.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 51.06% | 65.08% | 10.67% | -8.77% | 0.44% |
| Total Current Assets | 28.41% | 34.64% | -18.15% | -22.37% | -5.22% |
|
|
|||||
| Total Current Assets | 28.41% | 34.64% | -18.15% | -22.37% | -5.22% |
| Net Property, Plant & Equipment | -42.35% | -29.17% | -22.08% | -17.65% | -14.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -62.42% | 172.16% | 39.68% | 0.00% | 0.80% |
| Total Assets | 21.17% | 25.06% | -21.62% | -6.07% | -5.23% |
|
|
|||||
| Total Accounts Payable | 46.13% | -6.97% | 15.39% | -18.60% | 21.88% |
| Total Accrued Expenses | 0.59% | 83.15% | -36.60% | 28.68% | 27.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -42.86% | -28.99% | -14.81% | 3.18% | 3.29% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.79% | 51.59% | -25.01% | 13.93% | 25.33% |
|
|
|||||
| Total Current Liabilities | 9.79% | 51.59% | -25.01% | 13.93% | 25.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -75.00% | -42.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.79% | 51.59% | -25.08% | 13.60% | 24.78% |
|
|
|||||
| Common Stock & APIC | 15.39% | 15.58% | 1.83% | 0.20% | 0.28% |
| Retained Earnings | -10.47% | -10.37% | -27.02% | -9.48% | -10.43% |
| Treasury Stock & Other | 1,244.44% | -5.88% | 91.94% | -- | -- |
| Total Common Equity | 22.06% | 23.37% | -21.39% | -7.15% | -6.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.06% | 23.37% | -21.39% | -7.15% | -6.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.06% | 23.37% | -21.39% | -7.15% | -6.46% |
|
|
|||||